Support & Solvents
Injection Kit
50 syringes + 100 padsEverything required to safely reconstitute and inject reconstituted peptides — 50 sterile insulin syringes plus 100 alcohol prep pads.
$25
39-AA triple agonist · LY3437943 · ~6-day half-life · Aib-substituted, C20 fatty-diacid
First-in-class triple agonist of GIP, GLP-1 and glucagon receptors — extended half-life via fatty-acid acylation.
ロット別分析報告書 — HPLC、ESI-MS、LALエンドトキシン、重金属、滅菌性
Buy Retatrutide 10mg at IGF1 Shop. Retatrutide, also known as 3-GLP or LY3437943, is a first-in-class synthetic 39-amino-acid peptide that simultaneously activates three metabolic receptors: GLP-1, GIP, and glucagon. This triple-agonist design is what sets Retatrutide apart from single-agonist Semaglutide and dual-agonist Tirzepatide. Strategic α-aminoisobutyric acid (Aib) substitutions confer protease resistance, and a C20 fatty diacid attached via γGlu-spacer at Lys17 produces high-affinity albumin binding with a serum half-life of approximately 6 days. Each Retatrutide 10mg vial is HPLC-verified at ≥99% purity, ESI mass-spec confirmed against the theoretical 4,731.4 Da molecular weight, and accompanied by a per-lot Certificate of Analysis. CAS 2381089-83-2.
別名: Retatrutide · 3-GLP · LY3437943 · Triple agonist peptide
Retatrutide (LY3437943, project name 3-GLP) is a 39-amino acid synthetic peptide engineered as a single-molecule agonist of three incretin and metabolic receptors simultaneously. Strategic α-aminoisobutyric acid substitutions confer protease resistance, and a C20 fatty diacid attached via γGlu-spacer at Lys17 produces high-affinity albumin binding with a serum half-life of ~6 days.
3-GLP (Retatrutide)のすべてのロットは、逆相HPLC(参照標準に対して220 nmで面積純度≥ 99%)、分子量のESI質量分析確認、および0.5 EU/mg未満のLimulus Amebocyte Lysate(LAL)エンドトキシン試験に合格した後にのみリリースされます。ロット固有の分析証明書は注文に同梱され、購入前にリクエストに応じて提供可能です。